XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ 622,431 $ 623,046
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 586,821 309,914
Amortization of deferred financing costs 13,419 9,716
Non-cash interest expense related to amortization of discount on Life Storage unsecured senior notes 32,563 8,228
Compensation expense related to share-based awards 14,417 19,433
Accrual of interest income added to principal of debt securities and notes receivable (23,455) (30,127)
Equity in earnings of unconsolidated real estate ventures - gain on sale of real estate assets and sale of a joint venture interest (13,730) 0
Impairment of Life Storage trade name 51,763 0
Loss on real estate assets held for sale 63,620 0
Distributions from unconsolidated real estate ventures 21,839 11,484
Changes in operating assets and liabilities:    
Other assets 45,737 (31,675)
Accounts payable and accrued expenses 45,145 134,310
Other liabilities 18,581 (16,370)
Net cash provided by operating activities 1,479,151 1,037,959
Cash flows from investing activities:    
Acquisition of real estate assets and improvements (361,126) (197,333)
Life Storage Merger, net of cash acquired 0 (1,182,411)
Development and redevelopment of real estate assets (100,507) (66,533)
Proceeds from sale of real estate assets and investments in real estate ventures 4,415 2,132
Investment in unconsolidated real estate entities (7,175) (179,258)
Return of investment in unconsolidated real estate ventures 12,999 0
Issuance and purchase of notes receivable (739,702) (210,712)
Principal payments received from notes receivable 153,971 73,514
Proceeds from sale of notes receivable 175,335 134,064
Purchase of equipment and fixtures (15,713) (9,515)
Net cash used in investing activities (877,503) (1,636,052)
Cash flows from financing activities:    
Proceeds from unsecured term loans and senior notes and revolving lines of credit 5,542,362 5,194,665
Principal payments on unsecured term loans and senior notes and revolving lines of credit (6,062,896) (4,617,755)
Proceeds from issuance of public bonds, net 1,000,000 950,000
Deferred financing costs (12,633) (51,359)
Proceeds from share issuances 365 0
Offering costs associated with shelf registration (522) 0
Contributions from noncontrolling interests 15 0
Dividends paid on common stock (1,031,044) (704,069)
Distributions to noncontrolling interests (48,053) (43,003)
Net cash (used in) provided by financing activities (612,406) 723,479
Net (decrease) increase in cash, cash equivalents, and restricted cash (10,758) 125,386
Cash, cash equivalents, and restricted cash, beginning of the period 105,083 97,735
Cash, cash equivalents, and restricted cash, end of the period 94,325 223,121
Supplemental schedule of cash flow information    
Interest paid 381,434 207,569
Income taxes paid 30,635 20,222
Redemption of Operating Partnership units held by noncontrolling interests for common stock    
Noncontrolling interests in Operating Partnership 58,375 116,336
Common stock and paid-in capital (58,375) (11,336)
Noncontrolling interests in Operating Partnership Note Receivable Payoff 0 (100,000)
OP Unit Redemption - Cash Proceeds 0 (5,000)
Accrued Construction Costs And Capital Expenditures [Abstract]    
Acquisition of real estate assets 9,094 6,835
Accounts payable and accrued expenses (9,094) (6,835)
Series A Preferred Stock    
Cash flows from financing activities:    
Redemption of Preferred A Units for cash $ 0 $ (5,000)